Cytokines and growth factors within the TME, including interleukin-6 (IL-6) and transforming growth factor-beta (TGF-β), further promote the plasticity and self-renewal capabilities of progenitor cells, enabling their adaptation to the tumor niche [[15], [16], [17]]. The gene discussed is IL6; the disease is neoplasm.